Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Guidance Document - Human-Use Antiseptic Drugs (PDF Version - 1.2 MB) Contact name: NNHPD Client Service Unit July 31, 2019 Notice Application of the Guidance Document: Human-Use Antiseptic Drugs The Human-Use Antiseptic Drugs (HUAD) guidance document applies to professional and…
Guidance on terms and conditions for class II to IV medical devices Download in PDF format (630 KB, 18 pages) Organization: Health Canada Date published: April 1, 2026 On this page Purpose Introduction Scope and application Policy objectives and statements Note about guidance…
Draft guidance on human and veterinary drug submissions based on promising evidence and terms and conditions: Overview Overview About terms and conditions Before filing a submission Submission screening and review Labelling and advertising Post-market safety Compliance and…
Consultation: Draft guidance on human and veterinary drug submissions based on promising evidence and terms and conditions Current status: Open Opened on December 12, 2025 and will close on February 10, 2026 Health Canada is seeking feedback on the Draft guidance on human and…
Draft guidance on terms and conditions for human and veterinary drugs: Overview Overview About terms and conditions Terms and conditions letters Progress reporting Filing information and review Compliance and enforcement Download in PDF format (1,206 KB, 32 pages) Organization:…
Consultation: Draft guidance on terms and conditions for human and veterinary drugs Current status: Open Opened on December 12, 2025 and will close on February 10, 2026 Health Canada is seeking feedback on the Draft guidance on terms and conditions for human and veterinary drugs…
Guidance Document for Source Establishments - Reporting Adverse Reactions to Human Cells, Tissues and Organs 1. Introduction 1.1 Scope This guidance document provides source establishments with assistance on how to comply with adverse reaction reporting obligations under the Food…
Revised Guidance Document: Acetaminophen Labelling Standard (PDF Version - 224 KB) Contact: Natural and Non-prescription Health Products Directorate September 15, 2016 Notice Our file number: The final version of the Health Canada Revised Guidance Document - Acetaminophen…
About the Medical Dictionary for Regulatory Activities Health Canada is collaborating with our international partners on issues related to drug and medical device clinical trials, authorizations, risk assessments, and potential shortages. Learn about how we are engaging our…
Medical devices for COVID-19: Conducting a clinical trial Conducting a clinical trial List of authorized clinical trials On this page Clinical trials regulations Applying to conduct a clinical trial for COVID-19 purposes Clinical trial regulations Clinical trials, or…
Early release: coverage and features are still expanding.
